π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Gallium-68-DOTATOC binds primarily with high affinity to somatostatin subty...
Status
Recruiting
Location
Veronique Roch
Start Date
2023-02-02
Trial ID
NCT06467968
Treatments Being Tested
Neuroendocrine cancer is an unusual disease and often goes undetected by ro...
Status
Unknown
Location
Ochsner Medical Center - Kenner
Start Date
2014-03
Trial ID
NCT02038738
This clinical trial studies gallium Ga 68-edotreotide positron emission tom...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2013-04-01
Trial ID
NCT01869725
The purpose of this study is to use a new type of scan, called 68Ga-DOTATOC...
Status
No Longer Available
Location
Memorial Sloan Kettering Cancer Center
Start Date
TBD
Trial ID
NCT02358018
Treatments Being Tested
This is a research study to collect information regarding usefulness of pos...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2019-03-28
Trial ID
NCT03873870
Treatments Being Tested
To evaluate 68Ga-DOTATATE PET/CT for staging of patients with carcinoid, ne...
Status
No Longer Available
Location
UCLA Hospital
Start Date
TBD
Trial ID
NCT02174679
Treatments Being Tested
The biology of pancreatic neuroendocrine tumors can change during the disea...
Status
Unknown
Location
Akademiska Sjukhuset
Start Date
2019-01-30
Trial ID
NCT03741517
Treatments Being Tested
This is a Phase 2 peptide receptor radionuclide therapy trial of 90Y-DOTATO...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2017-09-29
Trial ID
NCT03273712
This phase II trial investigates how well 177Lu-DOTATATE works in treating ...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2026-06-30
Trial ID
NCT04529044
the investigators will follow up after patients with neuroendocrine tumors ...
Status
Unknown
Location
Sheba Medical Center
Start Date
2020-11
Trial ID
NCT04622631